Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 4

    1.

    Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.

    Koo YX, Tan DS, Tan IB, Tao M, Chow WC, Lim ST.

    Cancer. 2009 Nov 6. [Epub ahead of print]PMID: 19899164 [PubMed - as supplied by publisher]Related articles

    2.

    "Anti-HBc alone" in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients.

    Koo YX, Tan DS, Tan IB, Quek R, Tao M, Lim ST.

    World J Gastroenterol. 2009 Aug 14;15(30):3834-5.PMID: 19673031 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Hepatitis B virus reactivation in a patient with resolved hepatitis B virus infection receiving maintenance rituximab for malignant B-cell lymphoma.

    Koo YX, Tan DS, Tan IB, Tao M, Lim ST.

    Ann Intern Med. 2009 May 5;150(9):655-6. No abstract available. PMID: 19414854 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.

    Koo YX, Tan DS, Tan BH, Quek R, Tao M, Lim ST.

    J Clin Oncol. 2009 May 20;27(15):2570-1; author reply 2571-2. Epub 2009 Apr 13. No abstract available. PMID: 19364951 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...